Dr. John Thomas Dugan III, MD

Dr. Dugan practices at Medical Center Endoscopy in Houston, Texas.

Dr. Dugan's NPI, 1154677755, was assigned on August 1, 2012. Dr. Dugan graduated from McGovern Medical School in 2010. Dr. Dugan holds Texas license Q7550.

Dr. Dugan's primary practice is Medical Center Endoscopy, at 6560 Fannin Suite 600, Houston, TX 77030. The practice phone is (713) 790-1512.

Dr. Dugan's primary practice is Medical Center Endoscopy in Houston, Texas. Dr. Dugan is also affiliated with Houston Methodist Hospital. The medical group on file is Medical Clinic of Houston, LLP. Dmand AI also links Dr. Dugan to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dugan practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dugan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dugan is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Dugan is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Dugan treats.

CMS data shows 1,077 Medicare services from Dr. Dugan across 13 procedure codes in 2024, for 607 Medicare patients. Medicare paid $116,062 for them.

CMS counts 607 Medicare patients who saw Dr. Dugan in 2024. The largest group is 65 to 74, with 300 patients. 72% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dugan's median patient age at 65, with 50% women.

In 2024, Dr. Dugan wrote 1,367 Medicare Part D claims for 469 patients. 88% of them were for generic drugs. CMS names the drug for 1,238 of them, across 14 drugs with 11 or more claims each, at $68,219 in total drug cost. In 2023, CMS named 1,042 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dugan for performance year 2024, reported individually. Dr. Dugan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dugan as offering telehealth. CMS counts 169 procedures of colonoscopy by Dr. Dugan, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Dugan, published from 2011 to 2016. The most frequent topics are Gastroscopy. Dr. Dugan has published most often in Gastrointest Endosc. Dr. Dugan's most frequent co-authors are Shashideep Singhal, MD, Kulvinder Singh Bajwa, MD and Michael G. Swaby, MD.

CMS Open Payments shows 256 general payments to Dr. Dugan from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,556.

Dr. Dugan graduated from McGovern Medical School in 2010.

Dr. Dugan is in network with 7 carriers, including Aetna, United Healthcare and Aspirus Health Plan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.